بدائل البحث:
point decrease » point increase (توسيع البحث)
ns decrease » nn decrease (توسيع البحث), _ decrease (توسيع البحث), a decrease (توسيع البحث)
we decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
c decrease » c decreased (توسيع البحث), _ decrease (توسيع البحث), a decrease (توسيع البحث)
e point » _ point (توسيع البحث), 5 point (توسيع البحث), a point (توسيع البحث)
50 c » 5 c (توسيع البحث), 50 μ (توسيع البحث), 50 _ (توسيع البحث)
point decrease » point increase (توسيع البحث)
ns decrease » nn decrease (توسيع البحث), _ decrease (توسيع البحث), a decrease (توسيع البحث)
we decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
c decrease » c decreased (توسيع البحث), _ decrease (توسيع البحث), a decrease (توسيع البحث)
e point » _ point (توسيع البحث), 5 point (توسيع البحث), a point (توسيع البحث)
50 c » 5 c (توسيع البحث), 50 μ (توسيع البحث), 50 _ (توسيع البحث)
-
201
-
202
-
203
-
204
-
205
-
206
-
207
-
208
-
209
-
210
-
211
-
212
-
213
-
214
-
215
-
216
-
217
Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor
منشور في 2025"…We found that <b>9a</b>, bearing a pargyline moiety, is also able to selectively inhibit MAOB over MAOA (465-fold) with an IC<sub>50</sub> of 0.182 μM, being the first-in-class dual NOX2/MAOB covalent inhibitor. …"
-
218
Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma
منشور في 2024"…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …"
-
219
Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma
منشور في 2024"…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …"
-
220
Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma
منشور في 2024"…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …"